Amlitelimab is an investigational anti-OX40 ligand monoclonal antibody designed to normalize the overactive immune response in patients with atopic dermatitis.
New research on acetaminophen use during pregnancy; the chikungunya vaccine Ixchiq is withdrawn; FDA approves Nexplanon for up to 5 years of use; suicidal ideation warning removed from GLP-1s; at-home ...
PFS significantly higher with nivolumab, doxorubicin, vinblastine, and dacarbazine versus brentuximab vedotin-AVD.
Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral ...
HealthDay News — Some canned tuna associated with a 2025 recall has been pulled from grocery stores in 9 states, federal ...
More than 80% of patients with clinically meaningful benefit at 12 months maintain that benefit at 18 and 24 months.
Significantly longer progression-free survival seen among patients with previously untreated, PD-L1 advanced or metastatic ...
No evidence of association for CWF with birth weight or other birth outcomes in study of >11 million singleton births.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results